LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rapid Diagnostic Tests Evaluated for Pregnancy Malaria

By LabMedica International staff writers
Posted on 01 Nov 2012
Accurate diagnosis and prompt treatment of pregnancy-associated malaria (PAM) is essential to avert adverse nativity outcomes.

Rapid diagnostic tests (RDTs) are an ideal diagnostic complement to microscopy, due to their ease of use and adequate sensitivity in detecting even submicroscopic infections.

Scientists at the National Institute of Medical Research (Tanga, Tanzania) collaborated with other international centers to evaluate the immunochromatographic RDTs under field conditions. A cohort of 924 pregnant women was followed up from enrolment until delivery, and a total of 5,905 samples were collected. Of those, 5,167 venous and 388/650 placental blood samples, for which there were complete RDT and microscopy datasets, were randomly selected for analysis.

The accuracy and reliability of RDTs in diagnosing PAM was evaluated using microscopy and nested polymerase chain reaction (PCR). Venous and placental blood samples evaluated by histidine rich protein 2 (HRP-2) and parasite lactate dehydrogenase (pLDH) based RDT Parascreen, (Zephyr Biomedicals; Goa, India) or HRP-2 only RDTs Paracheck Pf (Orchid Biomedical Systems; Mumbai, India) and ParaHITf (Span Diagnostics Ltd.; Surat, India).

Overall 91 of 5,555 (1.6%) samples were positive for malarial parasite antigen based on RDTs, whereas 49 of 5,555 (0.9%) were positive by microscopy. Of the 91 RDT positive samples, 50.5% were microscopy positive, while 49.5% were microscopy negative. To test whether the 45 microscopy negative but RDT positive samples were genuinely negative or false positive, a species diagnostic PCR assay was performed. Intriguingly, 19 of the 45 (42.2%) microscopy negative were positive by PCR and only three samples were positive by microscopy but negative by RDT.

The authors concluded that RDTs outperform expert microscopy in detecting asymptomatic Plasmodium falciparum in pregnant women. Given the difficulties in establishing reliable microscopy based diagnostic services, RDTs are good alternative for the detection and in the management of malaria infections in pregnant women. RDTs can both be used to detect infections not cleared by intermittent preventive treatment during pregnancy (IPTp) or to detect infections where the malaria endemicity is too low to warrant IPTp. The study was published on June 21, 2012, in the Malaria Journal .

Related Links:
Tanzania National Institute of Medical Research
Zephyr Biomedicals
Orchid Biomedical Systems

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more